Admission Date:  [**2199-12-21**]              Discharge Date:   [**2200-1-18**]  Date of Birth:  [**2135-3-22**]             Sex:   M  Service: NEUROLOGY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 17813**] Chief Complaint: altered mental status  Major Surgical or Invasive Procedure: None  History of Present Illness:  64 year old male with Hx of cirrhosis [**1-20**] NASH, DM, HTN, CHF with EF 40%, CAD, seizure disorder, stage IV decubitus ulcer p/w low grade fever and lethargy.
Pt was found to have a temp of 99.6 at nursing home on day of admission.
he recd tylenol at NH and his temp came down to 98.6.
he had a neg head CT. CXR showed new LLL opacity.
CHF with EF 40% on ECHO in [**7-/2198**] 7.
Coronary artery disease status post cardiac catheterization in [**2187**] w/o stenting 8.
Family History: Non-contributory  Physical Exam: PHYSICAL EXAMINATION: VS: 98.2 150/75 87 22 93/3l GEN: NAD, awake, alert HEENT: EOMI, PERRL, sclera anicteric, conjunctivae clear, OP moist and without lesion NECK: Supple, no JVD CV: Reg rate, normal S1, S2.
ABD: Soft, NT, ND, no HSM EXT: No c/c/e SKIN: maculopapular rash on back   Pertinent Results: CXR: IMPRESSION: Study limited due to low inspiration.
Head CT: IMPRESSION: No evidence of hemorrhage seen.
DOPPLER EXAMINATION: Color and pulsed pulse-wave Doppler images were obtained.
Velocities of 27, 90 and 94 cm/sec.
L/SI Spine plain films and Pelvic plain films:      Brief Hospital Course: # Respiratory failure:  The patient developed respiratory failure during seziure activity and recent HCAP.
Sputum cultures were positive for klebsiella, proteus, sensitive to meropenem, zosyn and tobra however most likely contaminent not infection, and the patient was not started on antibiotics as the patient had received vanc/ceftriaxone/flagyl eariler in his hospital course.
He underwent an abdominal U/S of liver w/ normal TIPS evaluation with wall-to-wall flow.
Most recent echo with improved EF.
Insulin Regular Human 300 unit/3 mL Insulin Pen [**Month/Day (3) **]: 11-32 units  Subcutaneous three times a day: Per sliding scale: FS 71-100, 11 Units FS 101-150, 17 Units FS 151-200, 20 Units FS 201-250, 24 Units FS 251-300, 28 Units FS 301-350, 32 Units.
Your seizures were controlled with a combination of anti-epileptic medicines, which you should continue.
